المؤلفون: Anat Gafter-Gvili, Bernice Oberman, Maria Gomes da Silva, Marinus H. J. van Oers, Peter Dreger, Umberto Vitolo, Michele Ghielmini, Ofer Shpilberg, Mathias Witzens-Harig, Thomas M. Habermann, Liat Vidal, Laurence S. Freedman, Carmit Rubin, Hailun Li, Catherine Fortpied, Andrea Evangelista, Sami Bousseta, Ruth Pettengell, Gilles Salles

المساهمون: Electrical Engineering University of Leeds, Service d'hématologie [Hôpital Edouard Herriot - HCL], Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon ( HCL ) -Hospices Civils de Lyon ( HCL ), Centre de Recherche en Cancérologie de Lyon ( CRCL ), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Science for Life Laboratory Uppsala, Department of Medical Biochemistry and Microbiology, Uppsala University, Hematology, Academic Medical Center [Amsterdam] ( AMC ), University of Amsterdam [Amsterdam] ( UvA ) -University of Amsterdam [Amsterdam] ( UvA ), European Organisation for Research and Treatment of Cancer [Bruxelles] ( EORTC ), European Cancer Organisation [Bruxelles] ( ECCO ), Innere Medizin V, Medizinische Universitäts-Klinik und Poliklinik, Heidelberg University Hospital [Heidelberg], Instituto Português de Oncologia de Lisboa Francisco Gentil, China Agricultural University ( CAU ), Shanghai Jiao Tong University [Shanghai], Clinical Haematology

المصدر: European journal of cancer (Oxford, England : 1990)
European journal of cancer (Oxford, England : 1990), 2017, 76 (17), pp.216-225
European journal of cancer (Oxford, England, 76, 216-225. Elsevier Limited

مصطلحات موضوعية: Male, Oncology, Cancer Research, Follicular lymphoma, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Follicular, Randomized Controlled Trials as Topic, Aged, 80 and over, Hazard ratio, Induction Chemotherapy, Middle Aged, Survival Rate, Vincristine, 030220 oncology & carcinogenesis, Meta-analysis, Female, Rituximab, medicine.drug, Adult, medicine.medical_specialty, Maintenance, Antineoplastic Agents, Induction Phase, Infections, Disease-Free Survival, Maintenance Chemotherapy, Immunocompromised Host, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Overall survival, Humans, Adverse effect, Cyclophosphamide, Aged, Proportional Hazards Models, business.industry, Patient data, medicine.disease, Surgery, Doxorubicin, Multivariate Analysis, Prednisone, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e98e169ea2c5ae06e30694e469de7179Test
https://hal.archives-ouvertes.fr/hal-01568667Test

المؤلفون: Alain Delmer, Pierre Soubeyran, Guillaume Cartron, Thierry Lamy, Hervé Tilly, Christophe Fermé, Marie-Hélène Delfau-Larue, Sami Bousseta, Jacques Bienvenu, Lionel Karlin, Tioka Rabeony, Catherine Sebban, Gilles Salles, Pauline Brice, Pierre Feugier, Dominique Bordessoule, Rene-Olivier Casasnovas, Jehan Dupuis

المصدر: Blood. 124:4430-4430

مصطلحات موضوعية: CD20, medicine.medical_specialty, education.field_of_study, biology, business.industry, Tetanus, Immunology, Population, Follicular lymphoma, Cell Biology, Hematology, medicine.disease, Biochemistry, Chemotherapy regimen, Gastroenterology, Titer, Maintenance therapy, Internal medicine, biology.protein, Medicine, Rituximab, business, education, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::82cd210295ec9006581cee17b13d2295Test
https://doi.org/10.1182/blood.v124.21.4430.4430Test

المؤلفون: Maria Gomes da Silva, Ruth Pettengell, Carmit Rubin, Bernice Oberman, Peter Dreger, Sami Bousseta, Hailun Li, Ofer Shpilberg, Umberto Vitolo, Gilles Salles, Laurence S. Freedman, Mathias Witzens-Harig, Thomas M. Habermann, Liat Vidal, Anat Gafter-Gvili, Marinus H. J. van Oers, Catherine Fortpied, Andrea Evangelista

المصدر: Blood. 124:4462-4462

مصطلحات موضوعية: medicine.medical_specialty, Performance status, business.industry, Immunology, Hazard ratio, Cell Biology, Hematology, Biochemistry, Chemotherapy regimen, Surgery, law.invention, Log-rank test, Maintenance therapy, Randomized controlled trial, Median follow-up, law, Internal medicine, medicine, Progression-free survival, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ac24a38445f1d28ad0b6aede9232d104Test
https://doi.org/10.1182/blood.v124.21.4462.4462Test